Agency Information Collection Activities; Announcement of OMB Approval; Adverse Experience Reporting for Licensed Biological Products; and General Records

الملخص

The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Adverse Experience Reporting for Licensed Biological Products; and General Records" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.